StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) income statement

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.82+0.17 (+2.56%)

Close on Nov 18, 2026Market cap $341.32MP/E –Yield –

CapsoVision, Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
50.9%
Operating margin
-217.1%
Net margin
-214.7%
Return on equity, FY2025
43.6%

Financial strength

Current ratio
3.35
Debt to equity
–
Debt to assets
–
Cash to current liabilities
–

Valuation

P/E ratio
–
Price to sales
24.57
Price to book
25.92
Dividend yield
–

See a number that looks wrong?